Pharmaceutical composition containing a tetrahydrofolic acid

Details for Australian Patent Application No. 2007271449 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors King, Kristina

Agent Davies Collison Cave

Pub. Number AU-A-2007271449

PCT Pub. Number WO2008/003432

Priority 06014002.7 06.07.06 EP

Filing date 29 June 2007

Wipo publication date 10 January 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/525 (2006.01)

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/585 (2006.01)

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2008/003432 Priority application(s): WO2008/003432

25 August 2011 Alteration of Name

  The name of the applicant has been altered to Bayer Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271465-Method for retarding the setting of mortar and concrete surfaces

2007271431-Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-be nzyl)oxy]-phenethyl}amino)methyl] benzoic acid